ANDA 61453, held by Apothecon. Cloxacillin Sodium.
As of Nov 16, 2026, ANDA 61453 (Tegopen), held by Apothecon, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| TegopenEQ 125MG BASE/5ML ยท for solution;oral | Cloxacillin Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters